Reuters logo
BRIEF-Heron says submitted new drug application for cinvanti
January 12, 2017 / 1:48 PM / 10 months ago

BRIEF-Heron says submitted new drug application for cinvanti

Jan 12 (Reuters) - Heron Therapeutics Inc

* Heron announces submission of cinvanti NDA for the prevention of chemotherapy-induced nausea and vomiting (CINV)

* Expects NDA for cinvanti to be approved by FDA in late 2017 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below